Heartflow, Inc. Common Stock (HTFL) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $4.11B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Healthcare Information Services |
| Country | US | CEO | John Farquhar |
| IPO Date | 2025-08-07 | CAGR | 42.1% |
| Employees | 843 | Website | www.heartflow.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $3.01B | P/E | -23.7 | Forward P/E | -191.84 | PEG | — |
| P/S | 4853.48 | P/B | 3688.68 | P/CF | -19750.25 | P/FCF | -17404.34 |
| Sales | $212.07M | Sales 1Y | 42.77% | Sales 3Y | — | Sales 5Y | — |
| EPS | $-2.01 | EPS 1Y | -1.39% | EPS 3Y | — | EPS 5Y | — |
| Sales QoQ | 21.86% | EPS QoQ | -43.75% | Sales QoQ Avg | 10.41% | EPS QoQ Avg | 96.34% |
| Gross Margin | 80.08% | Operating Margin | -34.31% | Profit Margin | -55.82% | ROCE | -24.23% |
| ROA | -34% | ROE | -42% | Altman Z Score | 33.64 | Piotroski Score | 4 |
| Current Ratio | 5.08 | Quick Ratio | 5.08 | Cash Ratio | 0.78 | Op. CF Ratio | -0.19 |
| Debt/Equity | 0.1 | Debt/Assets | 0.08 | Lt Debt/Equity | 0.07 | Lt Debt/Cap. | 0.07 |
| Intrst Cov. | -21.02 | Inventory Turnover | — | Asset Turnover | 0.62 | Receivables Turnover | 4.96 |
| Enterprise Value | $3.01B | P/E Ratio | -23.7 |
| Forward P/E | -191.84 | PEG Ratio | — |
| P/S Ratio | 4853.48 | P/B Ratio | 3688.68 |
| P/CF Ratio | -19750.25 | P/FCF Ratio | -17404.34 |
| EPS | $-2.01 | EPS Growth 1Y | -1.39% |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 42.77% | Gross Margin | 80.08% |
| Operating Margin | -34.31% | Profit Margin | -55.82% |
| ROE | -42% | ROA | -34% |
| ROCE | -24.23% | Current Ratio | 5.08 |
| Quick Ratio | 5.08 | Cash Ratio | 0.78 |
| Debt/Equity | 0.1 | Interest Coverage | -21.02 |
| Altman Z Score | 33.64 | Piotroski Score | 4 |
Heartflow, Inc. Common Stock (HTFL) valuation & financials
Heartflow, Inc. Common Stock (HTFL) has a market capitalization of $4.11B and trades at a price-to-earnings ratio of -23.7. It operates in the Healthcare sector (Medical - Healthcare Information Services).
Heartflow, Inc. Common Stock's revenue grew +42.8% over the last year.
Heartflow, Inc. Common Stock's next earnings report is scheduled for November 11, 2026 after market close (provider scheduled date); analysts estimate EPS of $-0.10. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)